inclusion criteria: 1. age ≥19 years at the time of signing informed consent form 2. body weight ≥45 kg at screening 3. laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 96 hours of randomization 4. oxygen saturation(spo2) \> 94% at randomization, in room air condition 5. willing and able to provide informed consent

inclusion criteria: 1. age ≥19 years at the time of signing informed consent form 2. body weight ≥45 kg at screening 3. laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 96 hours of randomization 4. oxygen saturation(spo2) \> 94% at randomization, in room air condition 5. willing and able to provide informed consent

inclusion criteria: age ≥19 years at the time of signing informed consent form body weight ≥45 kg at screening laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 96 hours of randomization oxygen saturation(spo2) > 94% at randomization, in room air condition willing and able to provide informed consent

inclusion criteria: age ≥19 years at the time of signing informed consent form body weight ≥45 kg at screening laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 96 hours of randomization oxygen saturation(spo2) > 94% at randomization, in room air condition willing and able to provide informed consent

inclusion criteria: 1. age ≥19 years at the time of signing informed consent form 2. body weight ≥45 kg at screening 3. laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 96 hours of randomization 4. oxygen saturation(spo2) > 94% at randomization, in room air condition 5. willing and able to provide informed consent

inclusion criteria: 1. age ≥19 years at the time of signing informed consent form 2. body weight ≥45 kg at screening 3. laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 96 hours of randomization 4. oxygen saturation(spo2) > 94% at randomization, in room air condition 5. willing and able to provide informed consent

inclusion criteria: 1. age ≥19 years at the time of signing informed consent form 2. body weight ≥45 kg at screening 3. laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 72 hours of randomization 4. oxygen saturation(spo2) > 94% at randomization, in room air condition 5. willing and able to provide informed consent

inclusion criteria: 1. age ≥19 years at the time of signing informed consent form 2. body weight ≥45 kg at screening 3. laboratory (rrt-pcr) confirmed infection with sars-cov-2 by testing specimens from upper airway (i.e. nasopharyngeal and oropharyngeal swab) or lower airway (i.e. sputum) within 72 hours of randomization 4. oxygen saturation(spo2) > 94% at randomization, in room air condition 5. willing and able to provide informed consent